Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
05/2005
05/12/2005CA2544255A1 Water-soluble compound
05/11/2005CN1200734C Treatment of refractory human tumors with epidermal growth factor receptor antagonists
05/10/2005US6890555 Liposome compositions of porphyrin photosensitizers
05/06/2005WO2005039554A2 Therapeutic use of methionine for the treatment or prevention of mucositis
05/06/2005WO2005039526A1 Method, reagent and device for embolizing capillary vessel in tumor with supersonic tiny-bubble reagent
05/06/2005WO2004064725A3 Oral compositions and methods for treatment of adverse effects or radiation
05/06/2005CA2543870A1 Therapeutic use of methionine for the treatment or prevention of mucositis
05/04/2005EP1526865A2 Compounds for targeting hepatocytes
05/03/2005US6887862 Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
05/03/2005US6887269 Ophthalmologic implant
05/03/2005US6887260 Method and apparatus for acne treatment
04/2005
04/28/2005WO2005037928A2 Compounds for dual photodiagnosis and therapy
04/28/2005WO2005037292A1 Mucous membrane bulging humor composition comprising chitosan derivative containing saccharide chain for use in condoscopic surgery
04/28/2005WO2005037259A2 Methods and compositions for the prevention or treatment of neoplasia comprising a cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist
04/28/2005WO2005021094A3 Antimicrobial photodynamic therapy compound
04/28/2005WO2004032963A9 Photokinetic delivery of biologically active substances using pulsed incoherent light
04/28/2005WO2003068929A3 Methods of inhibiting hiv-1 vpr activity and hiv-1 infectivity using atr or rad17 inhibitors
04/28/2005US20050090877 Phototherapeutic treatment of skin conditions
04/28/2005US20050090551 Therapeutic use of methionine for the treatment or prevention of mucositis
04/28/2005US20050090481 having improved stability and side effect reduction; tissue-targeted therapy
04/28/2005US20050090429 Photo-active backbone cyclized somatostatin analogs for photodynamic therapy and imaging
04/28/2005CA2543148A1 Mucous membrane bulging humor composition comprising chitosan derivative containing saccharide chain for use in condoscopic surgery
04/28/2005CA2542694A1 Compounds for dual photodiagnosis and therapy
04/27/2005EP1525478A2 SHIGA TOXIN B-SUBUNIT AS A VECTOR FOR TUMOR DIAGNOSIS AND DRUG DELIVERY TO GB sb 3 /sb EXPRESSING TUMORS
04/27/2005EP1525001A1 Conjugates of porphyrin compounds with chemotherapeutic agents
04/27/2005CN1198665C Method for introducing pharmaceutical drugs and nucleic acid into skeletal muscle
04/26/2005US6884817 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
04/21/2005WO2005034997A2 Conjugate of a photosensitiser and a bacteriophage
04/21/2005WO2005034912A2 Ferromagnetic particles and methods
04/21/2005WO2005034855A2 Photodynamic inactivation of bacterial spores
04/21/2005WO2004071386A3 Compositions comprising microcapsules containing magnetic nanoparticles and biologically active molecules, their preparation and use
04/21/2005US20050085725 Photoacoustic assay and imaging system
04/21/2005US20050084966 Methods for inducing the differentiation of blood monocytes into functional dendritic cells
04/21/2005US20050084538 Ultrasonic concentration of drug delivery capsules
04/21/2005CA2541369A1 Photodynamic inactivation of bacterial spores
04/14/2005WO2005017522A3 Method for in vivo determination on tested animals of the efficient concentration of deuterium depleted water for cancer therapy
04/14/2005WO2003051287A3 Topical compositions and methods for treatment of adverse effects of ionizing radiation
04/14/2005US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied
04/14/2005US20050079157 Combination bacteriolytic therapy for the treatment of tumors
04/13/2005EP1522313A1 Combination therapy of radiation and valdecoxib for the treatment of neoplasia
04/13/2005EP1521593A2 Transdermal botulinum toxin compositions
04/07/2005WO2005030329A1 Method of damaging biomolecule and biomolecule damaging apparatus
04/07/2005WO2005030317A2 Phototherapeutic treatment of skin conditions
04/07/2005WO2005030254A2 Conjugates for photodynamic therapy
04/07/2005WO2005030253A2 Photocleavable dna transfer agent
04/07/2005WO2005030118A2 Targeted release of nitric oxide in the cns circulation for modulating the bbb and treating disorders
04/07/2005WO2004096206A3 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor
04/07/2005WO2004066947A3 Hyperthermia oncolysis co-therapy
04/07/2005WO2004062624A3 Method of treating nausea, vomiting, retching or any combination thereof
04/07/2005US20050075268 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination
04/07/2005US20050074748 Bioreactive agents
04/07/2005US20050074506 Applying energy to blood brain barrier (BBB) region to break encapsulation; activating facilitator to promote passage of therapeutic and/or diagnostic agent
04/07/2005US20050074461 Transdermal botulinum toxin compositions
04/07/2005US20050074455 Treatment of neovascular opthalmic disease
04/07/2005CA2539924A1 Conjugates for photodynamic therapy
04/06/2005EP1519683A2 Solid hydrogel coupling for ultrasound imaging and therapy
04/05/2005US6874446 Animal brushes
03/2005
03/31/2005WO2004075819A3 Activation and production of radiolabeled particles
03/31/2005WO2004032876A3 Deguelin as a chemopreventive agent for lung cancer
03/31/2005US20050070518 Reduced fluence rate PDT
03/31/2005US20050069493 Administering a cobalamin linked with a diamino compound to a chelating group of a detectable metal, such as a radionuclide or paramagnetic metal ion
03/30/2005EP1253150B1 Polymeric micellar structure
03/30/2005EP1250093B1 Method for preventing fluorescence quenching
03/30/2005EP1250092B1 Method for preventing fluorescence quenching
03/30/2005CN1602172A Method and apparatus for the stimulation of hair growth
03/24/2005WO2005025508A2 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
03/24/2005WO2004043338A3 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
03/24/2005WO2003028640A3 In vivo panning for ligands to radiation-induced molecules
03/24/2005US20050064388 Methods and compositions for treating atheroma, tumors and other neoplastic tissue
03/24/2005US20050063995 mammalian tumor cells having been treated ex vivo by stressing with an oxidative environment such as ozone or oxygen and UV light simultaneously, to render the tumor cells effective to elicit an immune response to a melanoma, colon carcinoma or breast cancer tumor
03/24/2005US20050061335 Irrigation solution for use in ultrasound energy assisted surgery
03/24/2005CA2538395A1 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents
03/23/2005EP1404319A4 Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
03/22/2005CA2125189C Pyropheophorbides and their use in photodynamic therapy
03/17/2005WO2005023220A1 Non-polar photosensitizer formulations for photodynamic therapy
03/17/2005WO2005023096A2 Methods and compositions for ultrasound imaging of apoptosis
03/17/2005US20050058725 Gelatinase inhibitors; anticancer agents
03/17/2005US20050058599 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
03/17/2005CA2746516A1 Non-polar photosensitizer formulations for photodynamic therapy
03/16/2005EP1513560A2 Method of magnetically manipulating a cell with magnetisable particles
03/16/2005EP1204423B1 Therapeutic antibody against muc-1 antigen and methods for their use
03/16/2005EP1100394A4 Treatment of pigmented tissues using optical energy
03/16/2005CN1596303A Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
03/15/2005US6866992 Aqueous solution comprising sodium chloride, sodium citrate, sodium acetate, sodium phosphate and a psoralen; stoichiometry, nonsettling of psoralen
03/10/2005WO2005021094A2 Antimicrobial photodynamic therapy compound
03/10/2005WO2005020918A2 Ultrasonic concentration of drug delivery capsules
03/09/2005EP1512421A2 Method for collecting a desired blood component and performing a photopheresis treatment
03/09/2005EP1512420A2 Blood separation apparatus and method of using the same
03/09/2005EP1512399A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue
03/09/2005CN1592748A Separation of regioisomers of metal phthalocyanines
03/09/2005CN1191862C Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
03/03/2005WO2004110151A8 Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
03/03/2005WO2004103274A3 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/03/2005US20050049484 Methods and apparatus for monitoring and quantifying the movement of fluid
03/03/2005US20050049228 Antimicrobial photodynamic therapy compound and method of use
03/03/2005US20050048109 Non-polar photosensitizer formulations for photodynamic therapy
03/03/2005US20050048059 Binding to epitope which contains peptide and carbohydrate on tumor; anticancer agents
03/03/2005US20050048044 Controlling, adjustment diffusion or degradation of membrane using activating energy source such as light source or ultraviolet radiation
03/03/2005US20050047958 Methods for sterilizing preparations of digestive enzymes
03/02/2005EP1510225A2 Photochemotherapeutic and diagnostic application using 5-ALA and precursors
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 95